Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

C. Sokollik | J. Borovička | T. Hinterleitner | P. Stadler | G. Marx | G. Rogler | B. Burnand | A. Macpherson | D. Semela | A. Schoepfer | C. Beglinger | A. Straumann | S. Vavricka | F. Seibold | P. Hruz | R. von Känel | R. Tutuian | V. Pittet | J. Rossel | G. Kullak-Ublick | G. Dorta | F. Froehlich | C. Oneta | C. Felley | B. Müllhaupt | M. Schelling | M. Landolt | M. Scharl | E. Burri | C. Mottet | P. Maerten | D. Belli | J. Thorens | R. Wiest | M. Fraga | C. Doerig | C. Braegger | J. Ezri | M. Schäppi | P. Bauerfeind | P. Juillerat | S. Boehm | P. Michetti | B. Misselwitz | J. Niess | F. Lehmann | C. Nichita | Tanja Grandinetti | N. Fournier | M. Steuerwald | R. Jost | Christoph Müller | D. Vouillamoz | A. Vonlaufen | B. Sauter | L. Biedermann | J. Zeitz | P. Frei | A. Nagy | C. Mueller | H. Werner | L. Degen | L. Petit | C. Manser | P. Wiesel | P. de Saussure | T. Ehmann | J. Schnegg | S. Schibli | M. Seirafi | R. Meier | D. Peternac | R. Furlano | B. Helbling | C. Hirschi | M. Maillard | D. Herzog | F. Viani | D. Rogler | S. Buyse | S. Begré | J. Binek | Michael Fried | M. Sidler | P. Mosler | J. Spalinger | M. Neagu | A. Nydegger | U. Marbet | M. Sawatzki | Claudia Anderegg | J. Bengoa | B. Bigler | M. Blattmann | Nora Brunner | P. Bühr | Matthias Cremer | D. Criblez | J. Delarive | B. Dora | Ali El-Wafa | M. Engelmann | M. Fliegner | C. Funk | Suzanne Gallot-Lavallée | M. Geyer | M. Girardin | Delphine Golay | B. Gysi | Horst G. Haack | Johannes Haarer | P. Hengstler | Cyrill Hess | K. Heyland | P. Hiroz | R. Iwata | Céline Keller | C. Knellwolf | C. Knoblauch | H. Köhler | R. Koller | C. Krieger-Grübel | P. Künzler | Rupprecht Lange | M. Manz | Christoph Matter | Martina Mendanova | B. Morell | P. Müller | C. Münger-Beyeler | Leilla Musso | N. Obialo | Cassandra Oropesa | Ueli Peter | Franziska Piccoli-Gfeller | J. Pilz | Nadia Raschle | R. Rentsch | Jean-Pierre Richterich | S. Rihs | M. A. Ritz | J. Roduit | Vanessa Rueger | Gaby Saner | S. Scharl | H. Schlauri | Sybille Schmid Uebelhart | Gian-Marco Semadeni | A. Senning | H. Spangenberger | Bigna Straumann-Funk | M. Sulz | Alexandra Suter | S. Tiedemann | J. Vögtlin | R. Vulliamy | Jürg Wermuth | Tina Wylie | Dorothee Zimmermann | M. Egger | Andrew J. Macpherson | Ronald Sophie Restellini | V. Rueger | Rémy Meier | Marc A. Sidler | George Marx | Barbara Dora | Sylvia Rihs | Holger Spangenberger

[1]  D. Katzka,et al.  Eosinophilic Esophagitis. , 2021, The New England journal of medicine.

[2]  C. Sokollik,et al.  Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study , 2018, Journal of Crohn's & colitis.

[3]  J. Borovička,et al.  Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS) , 2018, Inflammatory Intestinal Diseases.

[4]  G. Rogler,et al.  Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases , 2017, PloS one.

[5]  A. Schoepfer,et al.  Eosinophilic esophagitis: What can we learn from Crohn’s disease? , 2017, United European gastroenterology journal.

[6]  G. Rogler,et al.  Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment , 2017, Journal of pediatric gastroenterology and nutrition.

[7]  R. Rizzoli,et al.  Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC) , 2017, Inflammatory bowel diseases.

[8]  C. Braegger,et al.  Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients , 2017, European journal of gastroenterology & hepatology.

[9]  C. Sokollik,et al.  The Use of 5-Aminosalicylic Acid in Children and Adolescents With Inflammatory Bowel Disease , 2017, Journal of clinical gastroenterology.

[10]  The Swiss Ibd Cohort Study Group,et al.  Changes in health-related quality of life over a 1-year follow-up period in children with inflammatory bowel disease , 2017, Quality of Life Research.

[11]  B. Burnand,et al.  Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator , 2017, PLoS ONE.

[12]  G. Rogler,et al.  Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease , 2017, Inflammatory bowel diseases.

[13]  R. von Känel,et al.  Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  L. Mazzolai,et al.  Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort , 2016, Scandinavian journal of gastroenterology.

[15]  G. Rogler,et al.  Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort? , 2016, PloS one.

[16]  A. Schoepfer,et al.  Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way? , 2016, Journal of Crohn's & colitis.

[17]  G. Rogler,et al.  The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort , 2016, Digestion.

[18]  B. Burnand,et al.  Patients and gastroenterologists’ perceptions of treatments for inflammatory bowel diseases: do their perspectives match? , 2016, Scandinavian journal of gastroenterology.

[19]  V. Pittet,et al.  Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study , 2015, Inflammatory bowel diseases.

[20]  G. Rogler,et al.  Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease , 2015, Alimentary pharmacology & therapeutics.

[21]  G. Rogler,et al.  Assessment of Inflammatory Bowel Disease Patient's Needs and Problems from a Nursing Perspective , 2015, Digestion.

[22]  M. Landolt,et al.  Shorter time since inflammatory bowel disease diagnosis in children is associated with lower mental health in parents , 2015, Acta paediatrica.

[23]  B. Burnand,et al.  The gap between scientific evidence and clinical practice: 5‐aminosalicylates are frequently used for the treatment of Crohn's disease , 2014, Alimentary pharmacology & therapeutics.

[24]  G. Rogler,et al.  Risk Factors for Repetitive Ileocolic Resection in Patients with Crohn's Disease: Results of an Observational Cohort Study , 2014, Inflammatory bowel diseases.

[25]  G. Rogler,et al.  Smoking Cessation Alters Intestinal Microbiota: Insights from Quantitative Investigations on Human Fecal Samples Using FISH , 2014, Inflammatory bowel diseases.

[26]  B. Burnand,et al.  Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis. , 2014, Journal of Crohn's & colitis.

[27]  M. Landolt,et al.  Validation of the IMPACT-III quality of life questionnaire in Swiss children with inflammatory bowel disease. , 2014, Journal of Crohn's & colitis.

[28]  G. Rogler,et al.  Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients , 2014, Scandinavian journal of gastroenterology.

[29]  G. Rogler,et al.  Coping is excellent in Swiss Children with inflammatory bowel disease: results from the Swiss IBD cohort study. , 2014, Journal of Crohn's & colitis.

[30]  G. Rogler,et al.  Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation Rate , 2013, The American Journal of Gastroenterology.

[31]  U. Siebert,et al.  Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study , 2013, European journal of gastroenterology & hepatology.

[32]  G. Rogler,et al.  Penetrating or Stricturing Diseases are the Major Determinants of Time to First and Repeat Resection Surgery in Crohn's Disease , 2013, Digestion.

[33]  Ateequr Rehman,et al.  Smoking Cessation Induces Profound Changes in the Composition of the Intestinal Microbiota in Humans , 2013, PloS one.

[34]  U. Siebert,et al.  Predictors of Temporary and Permanent Work Disability in Patients With Inflammatory Bowel Disease: Results of the Swiss Inflammatory Bowel Disease Cohort Study , 2013, Inflammatory bowel diseases.

[35]  S. Ng,et al.  Geographical variability and environmental risk factors in inflammatory bowel disease , 2013, Gut.

[36]  J. González,et al.  Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project , 2012, Gut.

[37]  V. Pittet,et al.  Low prevalence of behavioural and emotional problems among Swiss paediatric patients with inflammatory bowel disease , 2012, Archives of Disease in Childhood.

[38]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[39]  A. Schoepfer,et al.  Quality of life: a potentially useful measure to indicate subclinical flares in Crohn disease , 2012, Internal medicine journal.

[40]  N. Caporaso,et al.  Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy. , 2012, Journal of Crohn's & colitis.

[41]  G. Rogler,et al.  Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[42]  A. Schoepfer,et al.  Mood and nonmood components of perceived stress and exacerbation of Crohn's disease , 2011, Inflammatory bowel diseases.

[43]  G. Kaplan,et al.  Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases , 2011, Inflammatory bowel diseases.

[44]  M. Rothenberg,et al.  Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies. , 2011, Journal of Allergy and Clinical Immunology.

[45]  R. von Känel,et al.  Effects of social support on the clinical course of Crohn's disease , 2011, Inflammatory bowel diseases.

[46]  G. Rogler,et al.  Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort , 2011, The American Journal of Gastroenterology.

[47]  G. Rogler,et al.  Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. , 2010, Journal of Crohn's & colitis.

[48]  R. von Känel,et al.  Avoidance and Inhibition Do Not Predict Nonrespondent Bias Among Patients With Inflammatory Bowel Disease , 2010, Journal of epidemiology.

[49]  J. Cosnes.  Smoking, Physical Activity, Nutrition and Lifestyle: Environmental Factors and Their Impact on IBD , 2010, Digestive Diseases.

[50]  B. Burnand,et al.  Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). , 2009, International journal of epidemiology.

[51]  M. Hoshen,et al.  Childhood Hygiene Is Associated With the Risk for Inflammatory Bowel Disease: A Population-Based Study , 2008, The American Journal of Gastroenterology.

[52]  G. Rogler,et al.  The role of domestic hygiene in inflammatory bowel diseases: hepatitis A and worm infestations , 2008, European journal of gastroenterology & hepatology.

[53]  F. Guarner.  Hygiene, microbial diversity and immune regulation , 2007, Current opinion in gastroenterology.

[54]  F. Guarner,et al.  Mechanisms of Disease: the hygiene hypothesis revisited , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[55]  J. Cosnes.  Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. , 2004, Best practice & research. Clinical gastroenterology.

[56]  A. Peña,et al.  Environmental risk factors in inflammatory bowel disease. , 1996, Hepato-gastroenterology.

[57]  F. Carbonnel,et al.  Effects of cigarette smoking on the long-term course of Crohn's disease , 1996 .

[58]  A. Schoepfer,et al.  Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up , 2017, European journal of gastroenterology & hepatology.